[1] |
Senior Department of Tuberculosis, the 8th Medical Center of Chinese PLA General Hospital , Editorial Board of Chinese Journal of Antituberculosis , Basic and Clinical Speciality Committees of Tuberculosis Control Branch of China International Exchange , Promotive Association for Medical and Health Care .
Expert consensus on multidisciplinary diagnosis and treatment of tuberculous peritonitis
[J]. Chinese Journal of Antituberculosis, 2025, 47(3): 243-257.
|
[2] |
Zhu Jiankun, Meng Qian, Kong Kangbao, Jin Feng.
The value of pneumonectomy in the treatment of pulmonary mucormycosis
[J]. Chinese Journal of Antituberculosis, 2025, 47(3): 274-281.
|
[3] |
He Zhongliang, Xu Weihua, Xin Shunxin, Chen Guoxing, He Xueming, Wang Lei.
The application value of individualized precision treatment for closure of bronchopleural fistula after lung cancer resection surgery
[J]. Chinese Journal of Antituberculosis, 2025, 47(3): 282-286.
|
[4] |
Fu Qiang, Shi Qinlang, Li Shaopeng, Zhou Zizi, Huang Pilai, Qiao Kun.
Application of Da Vinci robotic surgery combined with preoperative nourishing vascular pre-embolization in the surgical treatment of chronic pulmonary aspergillosis
[J]. Chinese Journal of Antituberculosis, 2025, 47(3): 287-291.
|
[5] |
Gong Sheng, Wang Ning, Li Dan, Li Gang, Liu Yu, Jiang Liangshuang, Yao Xiaojun.
Comparative study of fluorescence staining method and inflation-deflation method for thoracoscopic pulmonary tuberculosis segmentectomy
[J]. Chinese Journal of Antituberculosis, 2025, 47(3): 292-297.
|
[6] |
Chinese Antituberculosis Association, Editorial Board of Chinese Journal of Antituberculosis, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Research Institute, Inspire-CODA Research Group.
Expert consensus on the treatment of tuberculosis with contezolid
[J]. Chinese Journal of Antituberculosis, 2025, 47(2): 123-129.
|
[7] |
Li Xuelian, Zhang Hongyan, Wang Jun, Wang Qingfeng, Ma Liping, Chu Naihui, Nie Wenjuan.
Safety of extended delamanid use in drug-resistant tuberculosis patients
[J]. Chinese Journal of Antituberculosis, 2025, 47(2): 164-168.
|
[8] |
Yan Guangxuan, Wang Xueyu, Wang Yujin, Lan Tinglong, Nie Wenjuan.
Diagnostic value of using metagenomic second-generation sequencing on suspected osteoarticular tuberculosis patients
[J]. Chinese Journal of Antituberculosis, 2025, 47(2): 175-180.
|
[9] |
Chen Jifei, Huang Lihua, Luo Lanbo, Sui Wenxian, Pang Yu, Liu Aimei.
Evaluation the efficacy of tongue swab-based PCR fluorescence probe method for pulmonary tuberculosis
[J]. Chinese Journal of Antituberculosis, 2025, 47(1): 51-60.
|
[10] |
Chen Shuangshuang, Tian Lili, Wang Nenhan, Yang Xinyu, Zhao Yanfeng, Li Chuanyou, Dai Xiaowei.
Analysis of in vitro antibacterial effects of 17 antibiotics against rapidly growing mycobacteria in the Beijing area
[J]. Chinese Journal of Antituberculosis, 2024, 46(9): 1056-1062.
|
[11] |
Wang Biao, Liu Yuhong, Sun Yuxian, Zhang Lijie, Li Zhili, Shu Wei.
Investigation and analysis of laboratory diagnostic capabilities in tuberculosis-designated hospitals in China
[J]. Chinese Journal of Antituberculosis, 2024, 46(9): 1089-1097.
|
[12] |
Li Yang, Sun Feng, Zhang Wenhong.
Short-course treatment for tuberculosis: past achievements and future directions
[J]. Chinese Journal of Antituberculosis, 2024, 46(9): 991-997.
|
[13] |
Duan Hongfei.
Diagnosis and treatment of nontuberculous mycobacteria diseases in the past 60 years
[J]. Chinese Journal of Antituberculosis, 2024, 46(8): 863-868.
|
[14] |
Xue Yi, Liang Qian, Qi Haoran, Liang Ruixia, Huang Hairong.
Reliability analysis of rifampicin-resistance detected by different diagnostics as a predictor for multidrug-resistant tuberculosis
[J]. Chinese Journal of Antituberculosis, 2024, 46(8): 892-896.
|
[15] |
Han Wenya, Zhou Yangyu, Wang Meifang, Xue Xinying.
Progress in clinical diagnosis and treatment of pulmonary cryptococcosis
[J]. Chinese Journal of Antituberculosis, 2024, 46(7): 830-838.
|